Volume 41, Issue 11

Search all European Journal of Nuclear Medicine and Molecular Imaging articles

November 2014

31 articles in this issue

Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals
C. Decristoforo
I. Penuelas
A. Chiti
Editorial 03 July 2014 Pages: 2005 - 2007
Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma
Charles Lemarignier
Frédéric Di Fiore
Pierre Vera
Original Article 19 July 2014 Pages: 2008 - 2016
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
Myriam Sasanelli
Michel Meignan
Emmanuel Itti
Original Article 06 June 2014 Pages: 2017 - 2022
Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma
Jean François Grellier
Laetitia Vercellino
Pauline Brice
Original Article 26 June 2014 Pages: 2023 - 2030
Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma
Jun Sato
Yoshimasa Kitagawa
Nagara Tamaki
Original Article 28 May 2014 Pages: 2031 - 2041
Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy
Gaber Komar
Kaisa Lehtiö
Heikki Minn
Original Article 05 June 2014 Pages: 2042 - 2050
Metabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma
Do-Hoon Kim
Bong-Il Song
Byeong-Cheol Ahn
Original Article 03 July 2014 Pages: 2051 - 2057
Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
Carlos Caicedo
Maria Jose Garcia-Velloso
Jose Luis Perez Gracia
Original Article 03 July 2014 Pages: 2058 - 2065
Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients
Satoshi Takeuchi
Aparna Balachandran
Hubert H. Chuang
Original Article 03 July 2014 Pages: 2066 - 2073
Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo
H. Christian Rischke
Teresa Beck
Cordula A. Jilg
Original Article 21 June 2014 Pages: 2074 - 2082
¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study
Luka Lezaic
Sebastijan Rep
Jure Fettich
Original Article 26 July 2014 Pages: 2083 - 2089
Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging
Laura Gilardi
Chiara Maria Grana
Giovanni Paganelli
Editorial 11 July 2014 Pages: 2090 - 2092
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar
Joseph A. O’Donoghue
Steven M. Larson
Original Article 21 August 2014 Pages: 2093 - 2105
²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
C. Kratochwil
F. L. Giesel
A. Morgenstern
Original Article Open access 29 July 2014 Pages: 2106 - 2119
Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients
IL Han Choo
Stephen F. Carter
Agneta Nordberg
Original Article 31 July 2014 Pages: 2120 - 2126
Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys
Hideo Tsukada
Shingo Nishiyama
Norihiro Harada
Original Article 12 June 2014 Pages: 2127 - 2136
Do CSF levels of t-Tau, p-Tau and β_1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A ¹²³I-FP-CIT study in the early stages of the disease
Agostino Chiaravalloti
Alessandro Stefani
Orazio Schillaci
Original Article 10 July 2014 Pages: 2137 - 2143
The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition
K. Herholz
R. Evans
J. C. Matthews
Original Article 08 July 2014 Pages: 2144 - 2149
Molecular imaging: the emerging role of optical imaging in nuclear medicine
Fijs W. B. van Leeuwen
Marion de Jong
on behalf of the EANM Translational Molecular Imaging Committee; Marion de Jong, Fijs van Leeuwen, Tony Lahoutte, Laura Evangelista, Jacques Barbet, Silvana Del Vecchio, Roger Schibli.
Editorial 19 July 2014 Pages: 2150 - 2153
Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology
Eric Laffon
Roger Marthan
Letter to the Editor 12 August 2014 Pages: 2154 - 2154
Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and Marthan
Dirk Hasenclever
Lars Kurch
Regine Kluge
Letter to the Editor 12 August 2014 Pages: 2155 - 2157
FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment
Sandip Basu
Habib Zaidi
Abass Alavi
Letter to the Editor 04 July 2014 Pages: 2158 - 2160
Paolo Pozzilli, Andrea Lenzi, Bart L. Clarke, William F. Young Jr. (Eds): Imaging in Endocrinology
Manuela Amato
Luigi Mansi
Book Review 04 June 2014 Pages: 2161 - 2161
Wieslaw L. Nowinski and Beng Choon Chua (eds): The Human Brain in 1969 Pieces. Structure, Vasculature, Tracts, Cranial Nerves, Systems, Head Muscles, and Glands, Version 2.0
Luigi Mansi
Book Review 04 June 2014 Pages: 2162 - 2162
Weibo Cai (Ed.): Engineering in Translational Medicine
Luigi Mansi
Book Review 17 July 2014 Pages: 2163 - 2163
Erratum to: Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
Carlos Caicedo
Maria Jose Garcia-Velloso
Jose Luis Perez-Gracia
Erratum 16 September 2014 Pages: 2164 - 2164
Erratum to: Do CSF levels of t-Tau, p-Tau and β_1–42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A ¹²³I-FP-CIT study in the early stages of the disease
Agostino Chiaravalloti
Alessandro Stefani
Orazio Schillaci
Erratum 19 September 2014 Pages: 2165 - 2166
Widespread vascular inflammation in a patient with antineutrophil cytoplasmic antibody-associated vasculitis as detected by positron emission tomography
Soile P. Salomäki
Jukka Kemppainen
Laura Pirilä
Image of the Month 18 July 2014 Pages: 2167 - 2168
Ideas from the second UEMS conference on CME/CPD: new EU directives on a patients’ rights in cross-border healthcare and professional qualifications
Teresio Varetto
Durval C. Costa
UEMS/EBNM 31 July 2014 Pages: 2169 - 2173
Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)
Arturo Chiti
Editorial 21 August 2014 Pages: 2174 - 2174
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)
Sergio Todde
Albert D. Windhorst
Philip H. Elsinga
Guidelines 01 August 2014 Pages: 2175 - 2185

Volume 41, Issue 11

Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals

Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma

Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma

Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma

Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma

Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy

Metabolic parameters using ¹⁸F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma

Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients

Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo

¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study

Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging

⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer

²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience

Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients

Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys

Do CSF levels of t-Tau, p-Tau and β_1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A ¹²³I-FP-CIT study in the early stages of the disease

The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition

Molecular imaging: the emerging role of optical imaging in nuclear medicine

Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology

Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and Marthan

FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment

Paolo Pozzilli, Andrea Lenzi, Bart L. Clarke, William F. Young Jr. (Eds): Imaging in Endocrinology

Wieslaw L. Nowinski and Beng Choon Chua (eds): The Human Brain in 1969 Pieces. Structure, Vasculature, Tracts, Cranial Nerves, Systems, Head Muscles, and Glands, Version 2.0

Weibo Cai (Ed.): Engineering in Translational Medicine

Erratum to: Role of [¹⁸F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

Erratum to: Do CSF levels of t-Tau, p-Tau and β_1–42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A ¹²³I-FP-CIT study in the early stages of the disease

Widespread vascular inflammation in a patient with antineutrophil cytoplasmic antibody-associated vasculitis as detected by positron emission tomography

Ideas from the second UEMS conference on CME/CPD: new EU directives on a patients’ rights in cross-border healthcare and professional qualifications

Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Navigation